Liver transplantation is the sole definitive treatment for end-stage liver failure; however, its success is limited by a persistent imbalance between patients on the waitlist and the availability of potential donor organs1. To increase the donor pool, donor criteria have been gradually extended in the last decade, including older donor age, liver steatosis, and donation after circulatory death (DCD)2,3. During a DCD procedure, the liver invariably suffers a period of warm ischemia between the withdrawal of life-sustaining therapy, declaration of death, and in situ cooling and preservation, aggravating ischemia-reperfusion injury (IRI)4. As a result, DCD livers are associated with an increased incidence of early allograft dysfunction and biliary complications5,6.
For these high-risk donor livers, conventional preservation with static cold storage does not offer sufficient protection against IRI. Hereto, alternative preservation strategies such as normothermic machine perfusion (NMP) have gained considerable traction. During normothermic machine perfusion, the liver is connected ex situ to an isolated circuit and perfused with an oxygenated and nutrient-enriched perfusate at body temperature. Clinical trials suggest that NMP reduces hepatocellular injury, as reflected by reduced peak transaminase release and early allograft dysfunction7. However, little is known about liver cell biology during NMP8.
Animal models have been pivotal in the evolution of liver transplantation. In contrast to rodent models, the pig is considered to be of higher translational value as the porcine liver is anatomically and physiologically close to humans, with similar organ size and bile composition. Nevertheless, porcine liver transplant models are labor-intensive, difficult to standardize, and carry a significantly higher financial cost.
Porcine liver NMP can be used to serve different purposes. It can be applied to mimic transplantation ex situ when using a whole blood-based perfusate, to preserve a donor liver in a protective environment with a leukocyte-depleted red blood cell-based perfusate, to assess potential biomarkers predicting liver function ex situ prior to transplantation, or as a platform to investigate regenerative therapy9,10,11.
The adoption of porcine liver NMP models is challenging, while surgical and perfusion-related technical aspects are scarcely described. In our research laboratory, we adopted the NMP setup originally described by Butler et al.12 to develop and validate a 24 h porcine ex situ isolated liver perfusion model that could be used to both preserve a liver graft for transplantation and to mimic a transplant. Here, we describe a step-by-step protocol; a methodological framework and potential pitfalls are published elsewhere9.